XML 106 R91.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidating Financial Information - Statements of Cash Flows (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Asset impairment $ 6,301 $ 11,739 $ 0
Net cash (used in) provided by operating activities 321,184 242,299 229,123
Cash flows from investing activities:      
Capital expenditures, net of related payables (99,995) (102,649) (86,288)
Proceeds from asset sales 26,329 2,739 3,468
Investment in joint ventures (141) (5,811) (4,598)
Investments in subsidiaries 0 0 0
Distributions in excess of earnings from joint ventures 971 1,019 315
Distributions from subsidiaries 0 0 0
Proceeds from repayment of Native American development costs 0 66,048 0
Proceeds from repayment of advances to subsidiaries 0 0  
Loans to parent 0 0 0
Advances to subsidiaries     0
Native American development costs (1,827) (2,630) (3,551)
Other, net (1,994) 2 (2,376)
Net cash provided by (used in) investing activities (76,657) (41,282) (93,030)
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes 0 0 499,935
Repayment of Senior Notes 0 0 (625,000)
Borrowings under credit agreements with original maturity dates greater than three months 0 0 1,611,622
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 20,000 0 (5,000)
Payments under credit agreements with original maturities greater than three months (80,434) (68,129) (1,513,248)
Distributions to members and noncontrolling interests (173,241) (140,413) (56,684)
Payment of debt issuance costs 0 (2,454) (35,902)
Payments on derivative instruments with other-than-insignificant financing elements (8,947) (10,980) (9,039)
Loans from subsidiaries 0 0 0
Payments on advances from parent 0 0  
Advances from parent     0
Capital contributions from members 0 0 0
Capital contributions from noncontrolling interests 0 9,969 15,316
Other, net (9,261) (3,929) (9,352)
Net cash (used in) provided by financing activities (251,883) (215,936) (127,352)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents (7,356) (14,919) 8,741
Balance, beginning of year 122,702 137,621 128,880
Balance, end of year 115,346 122,702 137,621
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 120,206 127,868 117,240
Capital expenditures incurred but not yet paid 19,886 17,360 11,492
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest 0 0 4,600
Parent [Member]      
Asset impairment 201 0  
Net cash (used in) provided by operating activities (113,117) (118,162) (99,353)
Cash flows from investing activities:      
Capital expenditures, net of related payables (25,655) (32,614) (282)
Proceeds from asset sales 41 18 43
Investment in joint ventures 0 0 0
Investments in subsidiaries (129) (5,778) 0
Distributions in excess of earnings from joint ventures 0 0 0
Distributions from subsidiaries 28,741 21,818 21,383
Proceeds from repayment of Native American development costs   0  
Proceeds from repayment of advances to subsidiaries 180,142 170,439  
Loans to parent 0 0 0
Advances to subsidiaries     (499,381)
Native American development costs 0 0 0
Other, net (874) 714 6
Net cash provided by (used in) investing activities 182,266 154,597 (478,231)
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     499,935
Repayment of Senior Notes     (625,000)
Borrowings under credit agreements with original maturity dates greater than three months     1,611,622
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 20,000   (5,000)
Payments under credit agreements with original maturities greater than three months (77,277) (66,922) (936,831)
Distributions to members and noncontrolling interests (162,258) (130,319) (46,480)
Payment of debt issuance costs   (2,454) (33,248)
Payments on derivative instruments with other-than-insignificant financing elements (7,872) (8,948) (7,003)
Loans from subsidiaries 156,890 160,490 145,661
Payments on advances from parent 0 0  
Advances from parent     0
Capital contributions from members 0 0 0
Capital contributions from noncontrolling interests   0 0
Other, net (6,289) (1,910) (1,731)
Net cash (used in) provided by financing activities (76,806) (50,063) 601,925
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents (7,657) (13,628) 24,341
Balance, beginning of year 13,554 27,182 2,841
Balance, end of year 5,897 13,554 27,182
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 115,407 122,202 106,923
Capital expenditures incurred but not yet paid 5,685 2,063 0
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     0
Guarantor Subsidiaries [Member]      
Asset impairment 6,100 11,739  
Net cash (used in) provided by operating activities 409,708 361,733 326,171
Cash flows from investing activities:      
Capital expenditures, net of related payables (73,492) (66,871) (81,313)
Proceeds from asset sales 25,591 2,721 3,412
Investment in joint ventures (12) (33) (4,598)
Investments in subsidiaries 0 (13,531) (19,903)
Distributions in excess of earnings from joint ventures 971 1,019 315
Distributions from subsidiaries 11,236 10,094 10,202
Proceeds from repayment of Native American development costs   66,048  
Proceeds from repayment of advances to subsidiaries 0 0  
Loans to parent (156,890) (160,490) (145,661)
Advances to subsidiaries     0
Native American development costs (1,827) (2,630) (3,551)
Other, net (1,093) (762) (2,254)
Net cash provided by (used in) investing activities (195,516) (164,435) (243,351)
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     0
Repayment of Senior Notes     0
Borrowings under credit agreements with original maturity dates greater than three months     0
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 0   0
Payments under credit agreements with original maturities greater than three months 0 0 (573,562)
Distributions to members and noncontrolling interests (28,741) (21,818) (21,383)
Payment of debt issuance costs   0 (2,654)
Payments on derivative instruments with other-than-insignificant financing elements (1,075) (2,032) (2,036)
Loans from subsidiaries 0 0 0
Payments on advances from parent (180,142) (170,439)  
Advances from parent     499,381
Capital contributions from members 0 0 0
Capital contributions from noncontrolling interests   0 0
Other, net (2,972) (2,018) (822)
Net cash (used in) provided by financing activities (212,930) (196,307) (101,076)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents 1,262 991 (18,256)
Balance, beginning of year 104,575 103,584 121,840
Balance, end of year 105,837 104,575 103,584
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 1,367 2,383 10,272
Capital expenditures incurred but not yet paid 14,067 15,040 11,395
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     0
Parent and Guarantor Eliminations [Member]      
Asset impairment 0 0  
Net cash (used in) provided by operating activities 0 0 0
Cash flows from investing activities:      
Capital expenditures, net of related payables 0 0 0
Proceeds from asset sales 0 0 0
Investment in joint ventures 0 0 0
Investments in subsidiaries 0 0 0
Distributions in excess of earnings from joint ventures 0 0 0
Distributions from subsidiaries (28,741) (21,818) (21,383)
Proceeds from repayment of Native American development costs   0  
Proceeds from repayment of advances to subsidiaries (180,142) (170,439)  
Loans to parent 156,890 160,490 145,661
Advances to subsidiaries     499,381
Native American development costs 0 0 0
Other, net 0 0 0
Net cash provided by (used in) investing activities (51,993) (31,767) 623,659
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     0
Repayment of Senior Notes     0
Borrowings under credit agreements with original maturity dates greater than three months     0
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 0   0
Payments under credit agreements with original maturities greater than three months 0 0 0
Distributions to members and noncontrolling interests 28,741 21,818 21,383
Payment of debt issuance costs   0 0
Payments on derivative instruments with other-than-insignificant financing elements 0 0 0
Loans from subsidiaries (156,890) (160,490) (145,661)
Payments on advances from parent 180,142 170,439  
Advances from parent     (499,381)
Capital contributions from members 0 0 0
Capital contributions from noncontrolling interests   0 0
Other, net 0 0 0
Net cash (used in) provided by financing activities 51,993 31,767 (623,659)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents 0 0 0
Balance, beginning of year 0 0 0
Balance, end of year 0 0 0
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 0 0 0
Capital expenditures incurred but not yet paid 0 0 0
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     0
Parent and Guarantor Subsidiaries [Member]      
Asset impairment 6,301 11,739  
Net cash (used in) provided by operating activities 296,591 243,571 226,818
Cash flows from investing activities:      
Capital expenditures, net of related payables (99,147) (99,485) (81,595)
Proceeds from asset sales 25,632 2,739 3,455
Investment in joint ventures (12) (33) (4,598)
Investments in subsidiaries (129) (19,309) (19,903)
Distributions in excess of earnings from joint ventures 971 1,019 315
Distributions from subsidiaries 11,236 10,094 10,202
Proceeds from repayment of Native American development costs   66,048  
Proceeds from repayment of advances to subsidiaries 0 0  
Loans to parent 0 0 0
Advances to subsidiaries     0
Native American development costs (1,827) (2,630) (3,551)
Other, net (1,967) (48) (2,248)
Net cash provided by (used in) investing activities (65,243) (41,605) (97,923)
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     499,935
Repayment of Senior Notes     (625,000)
Borrowings under credit agreements with original maturity dates greater than three months     1,611,622
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 20,000   (5,000)
Payments under credit agreements with original maturities greater than three months (77,277) (66,922) (1,510,393)
Distributions to members and noncontrolling interests (162,258) (130,319) (46,480)
Payment of debt issuance costs   (2,454) (35,902)
Payments on derivative instruments with other-than-insignificant financing elements (8,947) (10,980) (9,039)
Loans from subsidiaries 0 0 0
Payments on advances from parent 0 0  
Advances from parent     0
Capital contributions from members 0 0 0
Capital contributions from noncontrolling interests   0 0
Other, net (9,261) (3,928) (2,553)
Net cash (used in) provided by financing activities (237,743) (214,603) (122,810)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents (6,395) (12,637) 6,085
Balance, beginning of year 118,129 130,766 124,681
Balance, end of year 111,734 118,129 130,766
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 116,774 124,585 117,195
Capital expenditures incurred but not yet paid 19,752 17,103 11,395
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     0
Non-Guarantor Subsidiaries [Member]      
Asset impairment 0 0  
Net cash (used in) provided by operating activities 24,593 (1,272) 2,305
Cash flows from investing activities:      
Capital expenditures, net of related payables (848) (3,164) (4,693)
Proceeds from asset sales 697 0 13
Investment in joint ventures (129) (5,778) 0
Investments in subsidiaries 0 0 0
Distributions in excess of earnings from joint ventures 0 0 0
Distributions from subsidiaries 0 0 0
Proceeds from repayment of Native American development costs   0  
Proceeds from repayment of advances to subsidiaries 0 0  
Loans to parent 0 0 0
Advances to subsidiaries     0
Native American development costs 0 0 0
Other, net (27) 50 (128)
Net cash provided by (used in) investing activities (307) (8,892) (4,808)
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     0
Repayment of Senior Notes     0
Borrowings under credit agreements with original maturity dates greater than three months     0
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 0   0
Payments under credit agreements with original maturities greater than three months (3,157) (1,207) (2,855)
Distributions to members and noncontrolling interests (22,219) (20,188) (20,406)
Payment of debt issuance costs   0 0
Payments on derivative instruments with other-than-insignificant financing elements 0 0 0
Loans from subsidiaries 0 0 0
Payments on advances from parent 0 0  
Advances from parent     0
Capital contributions from members 129 19,309 19,903
Capital contributions from noncontrolling interests   9,969 15,316
Other, net 0 (1) (6,799)
Net cash (used in) provided by financing activities (25,247) 7,882 5,159
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents (961) (2,282) 2,656
Balance, beginning of year 4,573 6,855 4,199
Balance, end of year 3,612 4,573 6,855
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 3,432 3,283 45
Capital expenditures incurred but not yet paid 134 257 97
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     4,600
Eliminations [Member]      
Asset impairment 0 0  
Net cash (used in) provided by operating activities 0 0 0
Cash flows from investing activities:      
Capital expenditures, net of related payables 0 0 0
Proceeds from asset sales 0 0 0
Investment in joint ventures 0 0 0
Investments in subsidiaries 129 19,309 19,903
Distributions in excess of earnings from joint ventures 0 0 0
Distributions from subsidiaries (11,236) (10,094) (10,202)
Proceeds from repayment of Native American development costs   0  
Proceeds from repayment of advances to subsidiaries 0 0  
Loans to parent 0 0 0
Advances to subsidiaries     0
Native American development costs 0 0 0
Other, net 0 0 0
Net cash provided by (used in) investing activities (11,107) 9,215 9,701
Cash flows from financing activities:      
Proceeds from issuance of 7.50% Senior Notes     0
Repayment of Senior Notes     0
Borrowings under credit agreements with original maturity dates greater than three months     0
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 0   0
Payments under credit agreements with original maturities greater than three months 0 0 0
Distributions to members and noncontrolling interests 11,236 10,094 10,202
Payment of debt issuance costs   0 0
Payments on derivative instruments with other-than-insignificant financing elements 0 0 0
Loans from subsidiaries 0 0 0
Payments on advances from parent 0 0  
Advances from parent     0
Capital contributions from members (129) (19,309) (19,903)
Capital contributions from noncontrolling interests   0 0
Other, net 0 0 0
Net cash (used in) provided by financing activities 11,107 (9,215) (9,701)
Cash and cash equivalents (including cash and cash equivalents of discontinued operations):      
(Decrease) increase in cash and cash equivalents 0 0 0
Balance, beginning of year 0 0 0
Balance, end of year 0 0 0
Supplemental cash flow disclosures:      
Cash paid for interest, net of amounts capitalized 0 0 0
Capital expenditures incurred but not yet paid $ 0 $ 0 0
Issuance of note payable with option by Fertitta Interactive in exchange for redemption of noncontrolling interest     $ 0